The 20 Best Renal Cell Carcinoma (RCC) Doctors Near Me

Dr. Porter provides state-of-the-art, minimally invasive treatment options to patients with urologic cancer and stone disease to reduce the pain and recovery from surgical treatment. He stays current on the latest available treatments by teaching at national and international urologic meetings as well as publishing his outcomes. Dr. Porter was the 2023 recipient of the Menon Award in Robotic Urologic Surgery. Dr. Porter is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Vasectomy. Dr. Porter is board certified in American Board Of Urology. Dr. Porter is currently accepting new patients.

David Mcdermott is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Mcdermott is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy. Dr. Mcdermott is board certified in American Board Of Internal Medicine.

I specialize in the care of patients with urologic cancers – mainly prostate cancer, kidney cancer, bladder cancer and testicular cancer. A cancer diagnosis is one of the scariest things that can happen to someone. For many of our patients, they don’t necessarily feel different or look different, but they are scared to death. The most important thing you can get from Duke is real understanding of your particular case and what your options are. Knowledge is so reassuring and empowering for patients, especially those recently diagnosed with cancer. When you’re first diagnosed, you have to put your trust in a care team, and that’s hard to do if you don’t already know them. As the largest cancer center in North Carolina, Duke has great reputation and experience, which helps many patients chose Duke for their care. But we grow and develop our trust with patients because of who we are as people and how much expertise and care we bring to each case. Dr. George is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Orchiectomy.

Mehmet Bilen is an Oncologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 18 years. Dr. Bilen is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Tissue Biopsy. Dr. Bilen is board certified in American Board Of Internal Medicine, 2016.

Nirmish Singla is an Oncologist practicing medicine in Lutherville, Maryland. Dr. Singla is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Singla is board certified in American Board Of Urology.

Jihad Kaouk is a Urologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 37 years. Dr. Kaouk is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Horseshoe Kidney, Nephrectomy, and Prostatectomy. Dr. Kaouk is board certified in American Board Of Urology, 2013.

Kenneth Ogan is a Urologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 31 years. Dr. Ogan is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Ureterocele, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Ureteroscopy. Dr. Ogan is board certified in American Board Of Urology, 2004.

Moshe Ornstein is an Oncologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 21 years. Dr. Ornstein is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Gamma Knife Radiosurgery. Dr. Ornstein is board certified in American Board Of Internal Medicine, 2017.

Dr. Michael A. Carducci is the AEGON Professor in Prostate Cancer Research at the Johns Hopkins University School of Medicine. He serves as the Vice Chair of Solid Tumor Oncology in the Department of Oncology. Dr. Carducci has an expertise in various types of cancer including prostate, kidney, and testicular. He also has an expertise in clinical trials, pain and palliative care for oncology, urological oncology, urology and medical oncology. A graduate of Georgetown University, Dr. Carducci received his medical degree with high distinction from Wayne State University School of Medicine. He completed an internal medicine internship, residency and chief residency at the University of Colorado Health Sciences Center. He went on to complete medical oncology and research fellowships at the Johns Hopkins Oncology Center at Johns Hopkins Hospital. He was promoted to Professor of Oncology and Urology in 2008 and installed into the inaugural AEGON Professorship in Prostate Cancer Research in 2009. He served as Co-Director of the GU Oncology program until 2013. In 2013, he assumed the leadership role of Associate Director for Clinical Research until being named Vice-Chair of Solid Tumor Oncology in 2024. A fellow of the American College of Physicians and a fellow of the American Society of Clinical Oncology, Dr. Carducci has received peer-reviewed funding for his clinical research from the National Cancer Institute, Department of Defense, and the Prostate Cancer Foundation. Mentorship of students, fellows, and junior faculty has been another focus of Dr. Carducci’s career in medicine, receiving numerous teaching awards. Dr. Carducci received the Michaele Christian Award and Lectureship for Oncology Drug Development at the National Cancer Institute in 2011. He chaired the Genitourinary Oncology Committee of ECOG-ACRIN from 2011-2024. In this role, he served on the GU Steering Committee for the NCI. Dr. Carducci is a member of the Investigational Drug Steering Committee for the NCI, and chaired that Committee for four years. He served as Associate Editor for GU Cancers for the Journal of Clinical Oncology from 2013-2024. Overall, his clinical research focus is on the development and evaluation of new therapies for urologic cancers. Incorporation of pharmacodynamics, novel biomarkers, and targeted imaging has been key elements of many of the trials led by Dr. Carducci. To complete these studies, Dr. Carducci facilitates and brings together a multidisciplinary team from urologists, radiation oncologists, pathologists, biostatisticians, and medical oncologists. Other areas of interest include palliative and end of life care, survivorship, and use of patient reported outcomes in clinical research and care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Carducci is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Carducci is board certified in American Board Of Internal Medicine.

Dr. Mohamad Allaf is Professor of Urology and Oncology, as well as Director of the Department of Urology and the Brady Urological Institute and Urologist-in-Chief of the Johns Hopkins Hospital. Dr. Allaf is a world renowned surgeon-scientist having performed more than 2,000 robotic procedures and published over 250 peer reviewed research papers in the field's best journals. As one of the busiest robotic radical prostatectomy surgeons in the world, he aims to achieve the best outcomes for his patients. Having trained with Dr. Patrick Walsh, Dr. Allaf has used Dr. Walsh's method of radical prostatectomy as the basis for his own anatomic method to this complex operation. Dr. Allaf is also amongst the leaders in kidney cancer surgery, having served on the American Urological Association Guideline Committee for Kidney Cancer. He led a team who performed the rigorous analysis to help inform the most recent guidelines that was funded by the Agency for Healthcare Research and Quality (AHRQ). He is best known for his ability to save the kidney and remove the tumor in patients with kidney tumors. Dr. Allaf runs a research endeavor aiming to decrease the morbidity associated with the treatment of cancer, and he has mentored numerous leaders in academic urology. He is actively involved in fund raising for research and education, and believes in expanding our base of support in order to advance our important mission. Dr. Allaf is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Renal Oncocytoma, Prostate Cancer, Nephrectomy, and Prostatectomy. Dr. Allaf is board certified in American Board Of Urology.

Omer Kucuk is an Oncologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 51 years. Dr. Kucuk is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Prostatectomy. Dr. Kucuk is board certified in American Board Of Internal Medicine, 1989.

Bradley Carthon is an Oncologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 21 years. Dr. Carthon is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Prostatectomy. Dr. Carthon is board certified in American Board Of Internal Medicine, 2011.

Wayne Harris is an Oncologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 38 years. Dr. Harris is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy. Dr. Harris is board certified in American Board Of Internal Medicine, 1999.

Robert Abouassaly is a Urologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 28 years. Dr. Abouassaly is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Bladder Cancer, Nephrectomy, and Penectomy. Dr. Abouassaly is board certified in American Board Of Urology, 2012.

Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications. Dr. Kavoussi is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Kavoussi is board certified in American Board Of Urology.

I am medical oncologist dedicated to the care of patients with genitourinary malignancies. My clinical and research focus is on the management of renal cell carcinoma (RCC). I have completed Medical Oncology Higher Specialist Training with Royal College of Physicians in Ireland and subsequently completed Advanced Medical Oncology Fellowship at the Memorial Sloan Kettering Cancer Center in New York. Dr. Ged is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Clear Cell Sarcoma, Nephrectomy, and Thrombectomy.

Daniel Eun is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Eun is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Upper Tract Urothelial Carcinoma (UTUC), Prostate Cancer, Ureteral Reconstruction, and Nephrectomy. Dr. Eun is board certified in Urology. Dr. Eun is currently accepting new patients.

Thomas Schwaab is a Urologist practicing medicine in Buffalo, New York. Dr. Schwaab is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Renal Oncocytoma, Nephrectomy, and Reconstructive Urology Surgery.

Venkatesh Krishnamurthi is a Transplant Surgeon practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 37 years. Dr. Krishnamurthi is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Krishnamurthi is board certified in American Board Of Urology, 2002.

Timothy Gilligan is an Oncologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 40 years. Dr. Gilligan is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Testicular Cancer, Urothelial Cancer, Nephrectomy, and Gamma Knife Radiosurgery. Dr. Gilligan is board certified in American Board Of Internal Medicine, 2002.